Tiptree Inc Dossier - Source-backed chat

Tiptree Inc

TIPTNASDAQ

SectorFinancials

IndustryProperty & Casualty Insurance

Beta (adjusted)0.96

Intrinsic Value

Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet.

Market Price $16.99Price as of 30 Sep 2026

Data confidence Sign in to view data confidence

Market Cap $632.7M

Enterprise Value $671.4M

Shares Outstanding 38M diluted

Next Earnings Date30 Oct 2026

Last ex-dividend18 May 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Tiptree Inc. has successfully unlocked massive shareholder value through the completion of the $1.65 billion sale of its specialty insurance subsidiary, Fortegra, to DB Insurance on May 29, 2026. This transaction, alongside the pending sale of its mortgage business, Reliance First Capital, has transformed Tiptree into a highly liquid capital allocator. The company's pro-forma book value stands at approximately $23.80 per diluted share ($912 million in total), representing a substantial premium over its current trading price of ~$17.70. With a clean balance sheet, the termination of its Fortress credit facility, and a newly authorized $20 million share buyback program, Tiptree offers a compelling margin of safety and a clear catalyst for re-rating as it redeploys capital into high-return financial services and specialty finance opportunities.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

Capital redeployment is slow or executed at lower-than-expected returns, leaving a large cash drag on the balance sheet. Holding company discount persists, and the market remains skeptical of management's ability to replicate the success of building Fortegra.

Base CaseCentral scenario

The market gradually recognizes Tiptree's simplified corporate structure and cash-rich balance sheet. The company successfully closes the Reliance First Capital sale for ~$50 million in mid-2026 and aggressively executes its $20 million share repurchase program, narrowing the discount to its pro-forma book value of $23.80.

Bull CaseUpside scenario

Tiptree Inc. offers a compelling post-restructuring book value discount thesis. Following the successful closing of the all-cash sale of its crown jewel specialty insurer, Fortegra, to DB Insurance for $1.65 billion (yielding $1.12 billion in gross proceeds to Tiptree) and the sale of Reliance First Capital, Tiptree has crystallized substantial cash value. This has simplified its corporate structure and boosted transparency. With an estimated pro-forma book value of $23.80 per diluted share against a trading price of around $16.96 to $17.67, the stock trades at a steep ~26% to 40% discount to its net asset value. This discount provides a strong margin of safety, with potential upside of 35%+ as the company deploys its massive cash pile into opportunistic share buybacks (including a newly authorized $20 million repurchase program) or new value-accretive acquisitions.

Scenarios reflect our research view at the research date.

Key Investment Merits

Substantial discount to pro-forma book value of $23.80 per share, providing a strong margin of safety.
Successful closing of the $1.65 billion Fortegra sale on May 29, 2026, validating management's long-term value creation strategy.
Clean balance sheet post-transaction, including the full repayment and termination of the Fortress credit agreement.
New $20 million share repurchase authorization to support opportunistic buybacks and enhance per-share metrics.

Key Investment Risks

Reinvestment risk as the company must find new high-return opportunities to replace the earnings power of Fortegra.
Holding company complexity and potential discount persistence if capital remains undeployed for an extended period.
Execution risk regarding the pending sale of Reliance First Capital in mid-2026.

Thesis Invalidation Triggers

Destructive capital allocation or overpaying for low-return acquisitions.
Failure to close the Reliance First Capital transaction under the agreed terms.
Inability to execute the share buyback program effectively despite the deep discount to book value.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.